EXAGEN INC. - Common Stock, par value $0.001 per share (XGN)

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
22,037,221
Total 13F shares
9,111,690
Share change
+2,874,688
Total reported value
$63,597,819
Price per share
$6.98
Number of holders
52
Value change
+$21,426,291
Number of buys
36
Number of sells
13

Institutional Holders of EXAGEN INC. - Common Stock, par value $0.001 per share (XGN) as of Q2 2025

As of 30 Jun 2025, EXAGEN INC. - Common Stock, par value $0.001 per share (XGN) was held by 52 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 9,111,690 shares. The largest 10 holders included RTW INVESTMENTS, LP, TORONTO DOMINION BANK, Balyasny Asset Management L.P., VANGUARD GROUP INC, Silvercrest Asset Management Group LLC, MORGAN STANLEY, Driehaus Capital Management LLC, UBS Group AG, WEXFORD CAPITAL LP, and KENNEDY CAPITAL MANAGEMENT LLC. This page lists 52 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.